a little johnson & johnson story, page-29

Hi Barradevil,

No, I don't "truly believe in the OBJ story". I prefer scientific language. The ASX is littered with failed stocks that have true believers.

The facts are:

- GSK is working on products with OBJ with the intention of marketing those products.

- P&G are exploring the possibility of making products with OBJ tech.

- Other companies are interested in OBJ tech.

- Many competitors exist and new ones keep rising up.

That is all. I don't know how long it will take, how much money will be involved, or if OBJ will even get to the finish line. My conclusion is that OBJ is a very worthwhile spec investment based on the few facts we have been given. Nevertheless, I maintain an open mind about new OBJ info. I'm on the lookout for both negative and positive info. If I get accurate negative info, I will sell. If I get accurate negative info, I will buy more.